Proton-pump inhibition acid-related disease Omeprazole lansoprazole forerunners group substituted benzimidazole compounds gastric proton pump drugs potent antisecretory effect final common pathway acid secretion Prolonged potent reduction acid secretion significant therapeutic advantage antisecretory medication receptor antagonists Research experience lansoprazole indicates treatment properties acid-related disease similar omeprazole Omeprazole treatment reflux esophagitis Zollinger-Ellison syndrome United past year approval first-line therapy duodenal ulcer disease Research individuals surveillance studies safety studies man animals omeprazole incidence spectrum adverse events clinical trials similar 